A Friday Flurry Of Biotech IPOs
A look at the four biotech companies going public Friday – which include two firms developing small molecule therapies to treat cancer.
Biotech IPOs
The Most Recent Biotech IPOs To Keep An Eye On
Biotech IPOs have helped drug developers raise over $5 billion so far this year.